Atrial Fibrillation Trial, Recruiting NCT06842147 Sponsor: Beijing Anzhen Hospital Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06842147
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 60 years or older
  • People who have never been diagnosed with atrial fibrillation (an irregular heartbeat condition)
  • People who are willing to be randomly assigned to a study group and attend follow-up appointments

Who may not be able to join:

  • People who have a pacemaker or an implanted heart device called a cardioverter-defibrillator (a device that delivers shocks to correct dangerous heart rhythms)
  • People who have difficulty with memory or thinking, or who are unable to give informed consent to participate
  • People whose life expectancy is estimated to be less than one year, such as those with advanced cancer or severe kidney disease
  • People the trial investigator considers unsuitable for the study for any reason
  • People who do not wish to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Anzhen Hospital
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
30 July 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Detection rate of new atrial fibrillation diagnoses; Composite endpoints

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov